Jan
2027
Paris Expo, Porte de Versailles - Hall 4 | Paris, France
Visit us
stand 4C86, General Zone
SHAILY INNOVATIONS LTD
Exhibitor at Pharmapack Europe 2027
About Us
Categories
-
Country/Region:United Kingdom
-
On CPHI since:2025
-
Certificates:3
-
Employees:250 - 499
Company types
Primary activities
Event information
Pharmapack Europe 2027
-
27 Jan 2027 - 28 Jan 2027
-
Paris Expo, Porte de Versailles - Hall 4 | Paris, France
-
Visit us at stand 4C86, General Zone
Products Featured at Pharmapack Europe 2027
-
Product Axiom
Axiom Platform Device - Product DescriptionThe Axiom is a fixed-dose pen injector developed for hormonal therapies such as Teriparatide, PTH, and FSH. It is designed to be non-priming, making it highly convenient for self-administration. With a compact form factor and intuitive operation, Axiom supports pr... -
Product Maxim
Maxim Platform Device - Product DescriptionThe Maxim is a reusable/disposable pen injector designed for self-medication in chronic therapies such as insulin and GLP-1. It combines precision dosing, ergonomic design, and regulatory compliance, making it ideal for both patients and pharmaceutical companies. -
Product ShailyPen Axiom Max and ShailyPen Neo (GLP-1 pens)
ShailyPen Neo™ and ShailyPen Axiom Max™ are key offerings from our comprehensive range of drug delivery systems. They are designed, engineered and manufactured for patient comfort, medication compliance and in-line with regulatory compliance and performance.
ShailyPen Neo is ... -
Product Shaily AI Toby™
Shaily AI Toby™ is a single-use, disposable device designed for subcutaneous and intramuscular drug delivery. It is part of Shaily’s platform of cost-effective, patient-centric self-medication systems, offering a robust yet low-complexity design.
-
Product Shaily AI Tristan™
Shaily AI Tristan™ is a patient-centric, self-medication device designed for subcutaneous and intramuscular drug delivery. It supports both 1.0ml pre-filled syringes (PFS) and 3.0ml cartridges (in development), making it versatile for a range of therapeutic applications....




